Sankey It
Loading...
Pfizer Inc. Q3 FY2025 income statement | Sankey It
Sankey It · PFE
Pfizer Inc. Q3 FY2025 income statement
USD · quarter ended 2025-09-28
Q2 FY2026
Q1 FY2026
Q4 FY2025
Q3 FY2025
Q2 FY2025
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Pfizer Inc. Q3 FY2025 income statement
Flow diagram with 7 nodes and 6 flows for Pfizer Inc. Q3 FY2025 income statement. Values: Revenue US$16.7B, Cost of Revenue US$4.2B, Gross Profit US$12.5B, Operating Expenses US$8.9B, Operating Income US$3.6B, Other Expense US$216M, Net Income US$3.5B.
Revenue
US$16.7B
Cost of Revenue
(US$4.2B)
25% of revenue
Gross Profit
US$12.5B
75% margin
Operating Expenses
(US$8.9B)
54% of revenue
Operating Income
US$3.6B
21% margin
Other Expense
(US$216M)
1% of revenue
Net Income
US$3.5B
21% margin
Net / profit
Tax / cost
Copy link
Share on X
Open full screen